Trial Profile
Effect of Baseline Dengue Serostatus Among Tetravalent Dengue Vaccine CYDTDV (Dengvaxia) Recipients on Subsequent Virologically Confirmed Dengue in the Philippines
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 May 2023
Price :
$35
*
At a glance
- Drugs CYD TDV (Primary)
- Indications Dengue
- Focus Pharmacodynamics
- 16 May 2023 Planned End Date changed from 1 Oct 2022 to 1 Jun 2023.
- 16 Mar 2018 New trial record